Company Profile

Jiangsu Putai Pharmaceutical Technology Co., Ltd. was established in 2020 and is a modern high-tech enterprise specializing in the research and development, production, sales, and service of daily health care products. Relying on the strong R&D platform and unique technical advantages of its parent company Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., it strives to build up the competitive advantages in terms of peptide products and technology, and is committed to becoming a benchmark enterprise in the industry, that is close to people's families and improves the quality of healthy life. The company has been adhering to the business philosophy of integrity, standardization, and steady development. As of now, the company has launched over 30 products in four major series, ProteLight® Wenning series, ProteLight® Otty series, ProteLight® Flowtide antimicrobial series, ProteLight® Dr. Germ series, covering antibacterial skin care, oral care, private hygiene and other aspects of personal care and health. In the future, the company will continue to innovate and expand its products and service scopes, develop more new products and series that are beneficial and effective for the public, meet people's increasingly diversified and personalized health needs, and serve public health.